Effects of prostadyn sabale capsules on chronic prostatitis / 中华男科学杂志

ABSTRACT

<p><b>OBJECTIVE</b>To study the effects of prostadyn sabale capsules on chronic prostatitis (CP).</p><p><b>METHODS</b>One hundred and twenty-five CP cases were divided into three categories according to National Institutes of Health (NIH) concensus definition and classification of CP31 of category II. 75 of category IIIA and 19 of category IIIB. All the cases were treated with prostadyn sabale capsules at the dosage of 320 mg twice a day. NIH chronic prostatitis symptom index (NIH-CPSI), routine examination and culture of expressed prostatic secretions (EPS) were prospectively evaluated before and after treatment.</p><p><b>RESULTS</b>The cure rates of category II, category IIIA and category IIIB were 25.8%, 16.0%, and 21.1% respectively, the general cure rate being 19.2%. The alleviation rate was 63.5% and the total effectivity rate was 82.7%. No side effects were observed.</p><p><b>CONCLUSIONS</b>Prostadyn sabale capsules have good effects on CP.</p>